BioCurity Pharmaceuticals
Mark Ratain is currently a member of the Scientific and Medical Advisory Board at BioCurity Pharmaceuticals. Mark has previously worked as a professor at UChicago Medicine in the cancer research center, the section of hematology/oncology, and the committee on clinical pharmacology and pharmacogenomics. Mark also served as the chairman of the committee on clinical pharmacology from 1992 to 2010.
Mark Ratain graduated from Yale University with an M.D. Mark also has an A.B. from Harvard University in Biochemical Sciences. Mark is certified by the American Board of Internal Medicine in Maintenance of Certification, Internal Medicine, Medical Oncology, and Hematology. Mark is also certified by the American Board of Clinical Pharmacology as a Diplomate. In addition, they are certified by the State of Illinois as a Licensed Physician and Surgeon. Finally, they are certified by the National Board of Medical Examiners as a Diplomate.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
BioCurity Pharmaceuticals
BioCurity Pharmaceuticals Inc. (“BioCurity”), is a clinical-stage biopharmaceutical company with a mission to positively transform radiation therapy for cancer patients, by addressing the global unmet need for an effective treatment to prevent toxicity from radiation therapy (radiation dermatitis).